The medical sector was strong all day, with the leading medical ETF, medical ETF, and medical industry ETF up 1%.

The situation is reversed.

Gelonghui FinanceSep 4, 2024 16:29

Fund product research: pharmaceutical leader ETF (515950): review faucet and elastic space

Content pharmaceutical leader ETF (515950) includes 50 sub-plate leaders in the pharmaceutical industry. ETF tracks the CSP50 index, index code 931140.CSI, the top 10 heavyweights accounted for 61.55% of the market capitalization on October 17, the top three sub-sectors are medical devices, medical services, chemical pharmaceuticals, the top three accounted for 70% of the market capitalization. The valuation of pharmaceutical leader ETF at the end of September matches the growth rate of future net profit. Most of the constituent stocks of ETF are covered by research, accounting for 96.58% of the market capitalization, and the bottom 9 of the market recently.

西部證券Oct 19, 2022 14:41 · Researches

Laying out a long-term high-quality circuit, the Fuguo China Securities Pharmaceutical 50 ETF link debuted today

The degree of aging in China continues to deepen, and the rapid improvement in residents' living standards has boosted demand in the pharmaceutical industry. The pharmaceutical industry is also seen as a “golden race track” for investment. However, issues such as the high professional threshold for investing in the pharmaceutical industry, the complexity of industry segments, and the difficulty of grasping valuations made investors “discouraged.” Recently, the pharmaceutical sector, which was sluggish earlier, has rebounded, and there has been an increase in the use of pharmaceutical funds to participate in investment. What are the advantages of investors using “infrastructure” to lay out pharmaceuticals at this time? Recent research by CICC's healthcare team shows that the current valuation of the medical sector is within a reasonable range. Data display, cutoff

證券時報Nov 23, 2021 09:30

Just this Saturday! Year 16 • 16th Shanghai Stock Exchange ETF Summit - Wells Fargo Fund Special is here!

After 16 years, ETFs have grown from young shoots in China to today's impressive trees. Since its inception at the end of 2004, the Chinese ETF market has seen endless product innovations, continuous diversification, and rapid growth in scale. Looking ahead, with the gradual maturity of China's capital market and growing investment demand from investors, ETFs still have a lot of room for development. Wells Fargo is willing to continue to expand its layout in the ETF market to provide investors with more instrument choices and create more value. Conference agenda 14:00-14:20 Leader's speech 14:20-15:10 2021 Investment Strategy Chairman of Haitong Securities

富國基金Mar 16, 2021 18:49

医药股年内波动大 基金经理把脉春季行情

证券时报Dec 22, 2020 02:57

The total size of 56 new stock ETFs issued during the year was 59.2 billion, doubling the year-on-year ratio of China Securities to 800 as popular targets

Since this year, A-shares have continued to fluctuate, and since July, there has been a roller coaster market. As the sector rotates at an accelerated pace, equity-traded open index funds (ETFs), which are powerful tools for investing in structured markets, have ushered in major expansion. According to the data, 56 equity ETFs have been established since this year, the total issuance scale has doubled year-on-year, and various types of ETF products have been expanded simultaneously. Whether looking at a single product or layout entity, the ETF market shows a situation where the strong are always strong. According to the year-on-year doubling of the total size of stock ETFs issued, based on the date of establishment, as of July 24, there have been 56 stock Es since this year

证券时报Jul 27, 2020 04:35